Discontinued — last reported Q2 '17
Newmont Long-Term Debt - Fair Value decreased by 2.4% to $5.16B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to book value may indicate rising interest rates or changes in credit risk, while a decrease may suggest favorable refinancing opportunities.
This represents the estimated market value of the company's long-term debt obligations if they were to be settled or tra...
Standard across large-cap pharmaceutical firms, often compared against total debt to assess interest rate sensitivity.
long_term_debt_fair_value| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $5.28B | $5.16B |
| QoQ Change | — | -2.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.